Toronto Dominion Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

Toronto Dominion Bank’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.9M	Buy	415,000 +414,838	+256,073%	+$10.3M	0.02%	588
2026 Q1	$3.39K	Sell	162 -31,538	-99%	-$710K	﹤0.01%	1986
2025 Q4	$729K	Buy	+31,700	New	+$1.04M	﹤0.01%	1315
2022 Q4	–	Sell	-19,700	Closed	-$816K	–	1575
2022 Q3	$816K	Buy	+19,700	New	+$1.01M	﹤0.01%	1128
2020 Q2	–	Sell	-30	Closed	-$1K	–	1351
2020 Q1	$1K	Hold	30	–	–	﹤0.01%	1208
2019 Q4	$1K	Buy	+30	New	+$1.24K	﹤0.01%	1315

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Toronto Dominion Bank's RARE Position: Q2 2026 in Review

Toronto Dominion Bank increased its Ultragenyx Pharmaceutical (RARE) stake by 256,073% in Q2 2026, buying an estimated $10.3M and bringing the position to 415,000 shares worth $13.9M. The position accounts for 0.02% of the portfolio, ranked #588.

Toronto Dominion Bank first reported a position in RARE in Q4 2019 and has held it in 6 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

Toronto Dominion Bank held 415,000 shares of Ultragenyx Pharmaceutical worth $13.9M as of Q2 2026.
Toronto Dominion Bank bought 414,838 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $10.3M.
Ultragenyx Pharmaceutical made up 0.02% of Toronto Dominion Bank's portfolio in Q2 2026, its #588 holding.
Toronto Dominion Bank first reported a position in Ultragenyx Pharmaceutical in Q4 2019 and has held it in 6 quarters since.
311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.